Stockscreener 앱 받기
0.00
100.00%
-2.04
시간 외 거래:
2.04
2.04
+
Organovo Holdings Inc 주식(ONVO)의 최신 뉴스
3D Bioprinted Organ Transplant Market Report: Insights, - openPR.com
VivoSim Labs, INC. SEC 10-K Report - TradingView
Organ On A Chip Market Is Booming So Rapidly 2025-2032Emulate, - openPR.com
3D Printed Organs Market Trends | Advancements in Kidney, Liver, - openPR.com
StockNews.com Initiates Coverage on Organovo (NASDAQ:ONVO) - Defense World
Organovo (NASDAQ:ONVO) Now Covered by Analysts at StockNews.com - Defense World
Organovo Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Organovo Holdings, Inc. Announces Board Appointments - marketscreener.com
Organovo Announces Close Of Sale Of FXR Program To Eli Lilly And Company - marketscreener.com
Organovo Holdings, Inc. and BICO Reach Licensing Agreement on Bioprinting Patents - marketscreener.com
VivoSim Labs introduces AI-driven drug testing models By Investing.com - Investing.com Canada
Organovo Holdings Rebrands to VivoSim Labs, Inc. - TipRanks
VivoSim Labs introduces AI-driven drug testing models - Investing.com Australia
FDA Shift Powers VivoSim's Game-Changing Drug Testing Tech: 50% Cost Reduction Target - Stock Titan
Organovo rebrands as VivoSim Labs, debuts new ticker By Investing.com - Investing.com South Africa
Organovo (ONVO) Rebrands to VivoSim Labs with New Ticker 'VIVS' - GuruFocus
Organovo (ONVO) Rebrands to VivoSim Labs with New Ticker 'VIVS' | ONVO Stock News - GuruFocus
Organovo rebrands as VivoSim Labs, debuts new ticker - Investing.com Australia
Organovo announces VivoSim to carry forward 3D bioprinting, legacy tech - TipRanks
VivoSim to Carry Forward Organovo 3D Bioprinting | ONVO Stock Ne - GuruFocus
Organovo Holdings Announces Transition to VivoSim Labs - TipRanks
VivoSim to Carry Forward Organovo 3D Bioprinting - The Manila Times
Organovo Holdings, Inc. Announces Name Change to VivoSim Labs, Inc. and New Ticker Symbol "VIVS" - Nasdaq
Strategic Transformation: Organovo Becomes VivoSim Labs to Accelerate 3D Bioprinting Innovation - Stock Titan
StockNews.com Begins Coverage on Organovo (NASDAQ:ONVO) - Defense World
Organovo stock plunges to 52-week low, touches $1.7 By Investing.com - Investing.com South Africa
Organovo (ONVO) Strengthens Position with FXR Program Sale - GuruFocus
Organovo (ONVO) Reports Preliminary Fiscal Year-End Cash Balance - GuruFocus
Organovo stock plunges to 52-week low, touches $1.7 - Investing.com Australia
Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Eli Lilly and Company’s Acquisition of FXR Program from Organovo - Global Legal Chronicle
Organovo (NASDAQ:ONVO) Earns Sell Rating from Analysts at StockNews.com - Defense World
Organ On A Chip Market Generated Opportunities, Future Scope - openPR.com
Organovo (ONVO) Anticipates $5M Cash Influx as Nasdaq Compliance Continues - GuruFocus
Organovo reports $11.3M cash balance in FY24 - MSN
Organovo expects to maintain Nasdaq listing with stable stock price By Investing.com - Investing.com India
Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements - The Manila Times
Organovo Holdings Expects to Meet Nasdaq Listing Requirements - TipRanks
Organovo expects to maintain Nasdaq listing with stable stock price - Investing.com
Organovo stock plunges to 52-week low of $2.13 amid steep decline - Investing.com Canada
ONVO Stock Quote Price and Forecast - CNN
Organovo Holdings (ONVO) Sells FXR Program to Lilly (LLY), Secures Financial Future - GuruFocus
1.11%
1.70%
자본화:
|
볼륨(24시간):